Cargando…

Substantial Improvement in UK Cervical Cancer Survival with Chemoradiotherapy: Results of a Royal College of Radiologists’ Audit

AIMS: To compare survival and late complications between patients treated with chemoradiotherapy and radiotherapy for locally advanced cervix cancer. MATERIALS AND METHODS: A Royal College of Radiologists’ audit of patients treated with radiotherapy in UK cancer centres in 2001–2002. Survival, recur...

Descripción completa

Detalles Bibliográficos
Autores principales: Vale, C.L., Tierney, J.F., Davidson, S.E., Drinkwater, K.J., Symonds, P.
Formato: Texto
Lenguaje:English
Publicado: W.B. Saunders 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2941040/
https://www.ncbi.nlm.nih.gov/pubmed/20594810
http://dx.doi.org/10.1016/j.clon.2010.06.002
_version_ 1782186876639117312
author Vale, C.L.
Tierney, J.F.
Davidson, S.E.
Drinkwater, K.J.
Symonds, P.
author_facet Vale, C.L.
Tierney, J.F.
Davidson, S.E.
Drinkwater, K.J.
Symonds, P.
author_sort Vale, C.L.
collection PubMed
description AIMS: To compare survival and late complications between patients treated with chemoradiotherapy and radiotherapy for locally advanced cervix cancer. MATERIALS AND METHODS: A Royal College of Radiologists’ audit of patients treated with radiotherapy in UK cancer centres in 2001–2002. Survival, recurrence and late complications were assessed for patients grouped according to radical treatment received (radiotherapy, chemoradiotherapy, postoperative radiotherapy or chemoradiotherapy) and non-radical treatment. Late complication rates were assessed using the Franco-Italian glossary. RESULTS: Data were analysed for 1243 patients from 42 UK centres. Overall 5-year survival was 56% (any radical treatment); 44% (radical radiotherapy); 55% (chemoradiotherapy) and 71% (surgery with postoperative radiotherapy). Overall survival at 5 years was 59% (stage IB), 44% (stage IIB) and 24% (stage IIIB) for women treated with radiotherapy, and 65% (stage IB), 61% (stage IIB) and 44% (stage IIIB) for those receiving chemoradiotherapy. Cox regression showed that survival was significantly better for patients receiving chemoradiotherapy (hazard ratio = 0.77, 95% confidence interval 0.60–0.98; P = 0.037) compared with those receiving radiotherapy taking age, stage, pelvic node involvement and treatment delay into account. The grade 3/4 late complication rate was 8% (radiotherapy) and 10% (chemoradiotherapy). Although complications continued to develop up to 7 years after treatment for those receiving chemoradiotherapy, there was no apparent increase in overall late complications compared with radiotherapy alone when other factors were taken into account (hazard ratio = 0.94, 95% confidence interval 0.71–1.245; P = 0.667). DISCUSSION: The addition of chemotherapy to radiotherapy seems to have improved survival compared with radiotherapy alone for women treated in 2001–2002, without an apparent rise in late treatment complications.
format Text
id pubmed-2941040
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher W.B. Saunders
record_format MEDLINE/PubMed
spelling pubmed-29410402010-10-13 Substantial Improvement in UK Cervical Cancer Survival with Chemoradiotherapy: Results of a Royal College of Radiologists’ Audit Vale, C.L. Tierney, J.F. Davidson, S.E. Drinkwater, K.J. Symonds, P. Clin Oncol (R Coll Radiol) Original Article AIMS: To compare survival and late complications between patients treated with chemoradiotherapy and radiotherapy for locally advanced cervix cancer. MATERIALS AND METHODS: A Royal College of Radiologists’ audit of patients treated with radiotherapy in UK cancer centres in 2001–2002. Survival, recurrence and late complications were assessed for patients grouped according to radical treatment received (radiotherapy, chemoradiotherapy, postoperative radiotherapy or chemoradiotherapy) and non-radical treatment. Late complication rates were assessed using the Franco-Italian glossary. RESULTS: Data were analysed for 1243 patients from 42 UK centres. Overall 5-year survival was 56% (any radical treatment); 44% (radical radiotherapy); 55% (chemoradiotherapy) and 71% (surgery with postoperative radiotherapy). Overall survival at 5 years was 59% (stage IB), 44% (stage IIB) and 24% (stage IIIB) for women treated with radiotherapy, and 65% (stage IB), 61% (stage IIB) and 44% (stage IIIB) for those receiving chemoradiotherapy. Cox regression showed that survival was significantly better for patients receiving chemoradiotherapy (hazard ratio = 0.77, 95% confidence interval 0.60–0.98; P = 0.037) compared with those receiving radiotherapy taking age, stage, pelvic node involvement and treatment delay into account. The grade 3/4 late complication rate was 8% (radiotherapy) and 10% (chemoradiotherapy). Although complications continued to develop up to 7 years after treatment for those receiving chemoradiotherapy, there was no apparent increase in overall late complications compared with radiotherapy alone when other factors were taken into account (hazard ratio = 0.94, 95% confidence interval 0.71–1.245; P = 0.667). DISCUSSION: The addition of chemotherapy to radiotherapy seems to have improved survival compared with radiotherapy alone for women treated in 2001–2002, without an apparent rise in late treatment complications. W.B. Saunders 2010-09 /pmc/articles/PMC2941040/ /pubmed/20594810 http://dx.doi.org/10.1016/j.clon.2010.06.002 Text en © 2010 Elsevier Ltd. https://creativecommons.org/licenses/by/3.0/ Open Access under CC BY 3.0 (https://creativecommons.org/licenses/by/3.0/) license
spellingShingle Original Article
Vale, C.L.
Tierney, J.F.
Davidson, S.E.
Drinkwater, K.J.
Symonds, P.
Substantial Improvement in UK Cervical Cancer Survival with Chemoradiotherapy: Results of a Royal College of Radiologists’ Audit
title Substantial Improvement in UK Cervical Cancer Survival with Chemoradiotherapy: Results of a Royal College of Radiologists’ Audit
title_full Substantial Improvement in UK Cervical Cancer Survival with Chemoradiotherapy: Results of a Royal College of Radiologists’ Audit
title_fullStr Substantial Improvement in UK Cervical Cancer Survival with Chemoradiotherapy: Results of a Royal College of Radiologists’ Audit
title_full_unstemmed Substantial Improvement in UK Cervical Cancer Survival with Chemoradiotherapy: Results of a Royal College of Radiologists’ Audit
title_short Substantial Improvement in UK Cervical Cancer Survival with Chemoradiotherapy: Results of a Royal College of Radiologists’ Audit
title_sort substantial improvement in uk cervical cancer survival with chemoradiotherapy: results of a royal college of radiologists’ audit
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2941040/
https://www.ncbi.nlm.nih.gov/pubmed/20594810
http://dx.doi.org/10.1016/j.clon.2010.06.002
work_keys_str_mv AT valecl substantialimprovementinukcervicalcancersurvivalwithchemoradiotherapyresultsofaroyalcollegeofradiologistsaudit
AT tierneyjf substantialimprovementinukcervicalcancersurvivalwithchemoradiotherapyresultsofaroyalcollegeofradiologistsaudit
AT davidsonse substantialimprovementinukcervicalcancersurvivalwithchemoradiotherapyresultsofaroyalcollegeofradiologistsaudit
AT drinkwaterkj substantialimprovementinukcervicalcancersurvivalwithchemoradiotherapyresultsofaroyalcollegeofradiologistsaudit
AT symondsp substantialimprovementinukcervicalcancersurvivalwithchemoradiotherapyresultsofaroyalcollegeofradiologistsaudit